Identification and validation of hypoxia-derived gene signatures to predict clinical outcomes and therapeutic responses in stage I lung adenocarcinoma patients

Rationale: The current tumour-node-metastasis (TNM) staging system is insufficient for precise treatment decision-making and accurate survival prediction for patients with stage I lung adenocarcinoma (LUAD). Therefore, more reliable biomarkers are urgently needed to identify the high-risk subset in...

Descrición completa

Gardado en:
Detalles Bibliográficos
Publicado en:Theranostics
Main Authors: Shi, Run, Bao, Xuanwen, Unger, Kristian, Sun, Jing, Lu, Shun, Manapov, Farkhad, Wang, Xuanbin, Belka, Claus, Li, Minglun
Formato: Artigo
Idioma:Inglês
Publicado: Ivyspring International Publisher 2021
Assuntos:
Research Paper
Acceso en liña:https://ncbi.nlm.nih.gov/pmc/articles/PMC7978303/
https://ncbi.nlm.nih.gov/pubmed/33754044
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.7150/thno.56202
Tags: Engadir etiqueta
Sen Etiquetas, Sexa o primeiro en etiquetar este rexistro!

Títulos similares